Clinical Trial Update: A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor [Phase 1, Phase 2]

View source ↗

Summary

This entry provides a status update on a phase 1/2 study of Eisai's E7386 in combination with other anticancer drugs for solid tumors. The trial is currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms
• Endometrial Neoplasms
• Hepatocellular Carcinoma
• Liver Neoplasms

Drugs mentioned

• E7386

Snippet

Sponsor: Eisai Inc. | Conditions: Endometrial Neoplasms, Neoplasms | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING